Virtify Will be Making a $5 Contribution to the The One Fund Boston for Each Visitor to Their Booth
If you are attending the DIA Annual meeting in Boston later this month, we invite you to come and see Virtify at booth number 1647.
Not only will you have the opportunity to learn about our newly launched product for Clinical and Regulatory Content Management – Virtify SCM, but we will be making a five dollar contribution to the The One Fund Boston for each visitor to our booth.*
Virtify is proud to call Boston home. As part of our commitment to keeping Boston Strong, we are pleased to be able to support The One Fund Boston which will be used to assist those families of the victims who were killed and the victims who were most seriously affected as a result of the tragic events during the Boston Marathon on April 15, 2013 and related events on April 18th and April 19th.
You may also find it worthwhile to come by our booth to learn about our exciting new product, Virtify SCM. Virtify SCM represents a groundbreaking approach to providing the pharmaceutical industry with powerful capabilities for collaborative / structured authoring and reviewing, content re-use, and workflow and content life cycle management. It has significant benefits across the organization in reducing overall cycle times, improving compliance, increasing efficiency, enhancing quality and improving decision-making. And you can receive more information about it and receive a brief demo during your visit to our booth or download a detailed SCM fact sheet that is available on our website.
If you would like to schedule a private demo or won’t be making it to DIA, but would like to find out more about Virtify SCM, contact Virtify at [email protected], +1 (617) 301-8708.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
